The objective of this study was to explore the pathophysiological relevance of WISP-2/CCN5 in progression of human pancreatic adenocarcinoma (PAC). We found WISP-2/CCN5 mRNA and protein expression was faint and sporadic in PAC and detected in only 8.7-20% of the samples with varying grades as compared to adjacent normal and chronic pancreatitis samples where expression was very high in the ducts and acini. Colocalization studies in tissue-microarray slides revealed WISP-2/CCN5 mRNA loss was associated with p53 overexpression in PAC. Like tissue samples, p53 mutant-PAC cell lines show loss of WISP-2/CCN5. Moreover, functional analysis studies demonstrate exposure of pancreatic cancer cells to WISP-2/CCN5 recombinant protein enhances mesenchymal-epithelial-transition (MET). Collectively, we suggest WISP-2/CCN5 silencing may be a critical event during differentiation and progression of PAC and mutant p53 is possibly an important player in pursuing this episode.
Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition. Publishing Authors By Initials
Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition. Journal Published:
PUBLICATION TYPE: Research Support, U.S. Gov't,
Journal: Cancer letters
VOLUME: 254
Page Numbers: 63-70
Journal Abbreviation: Cancer Lett.
ISSN: 0304-3835
DAY: 26
MONTH: 03
YEAR: 2007
Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 7600053
Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition. Keywords Mesh Terms:
KEYWORDS: Tumor Suppressor Protein p53
MESH TERMS: metabolism
Chemical & Substance for Abstract: Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition. Information
Substance Name: WISP2 protein, human
Registry Number: 0
Grant and Affiliation Information for Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition.
AFFILIATION: Cancer Research Unit, VA Medical Center, Kansas City, MO 64128, USA.
Country: Ireland
AGENCY: United States NCRR
GRANT: 1 P20 RR15563
ACRONYM: RR
MEDLINETA: Cancer Lett
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition Related Publications